Eizen Joshua M
See Remarks
Eizen Joshua M has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.
On the most recent filing, Eizen Joshua M is listed as See Remarks at AN2 Therapeutics, Inc. Inside the rolling window, Eizen Joshua M reported no open-market purchases and 4 open-market sales totaling $53K in ANTX. The largest disclosed transaction in the window is a sale of 5,945 ANTX shares on Jul 8, 2026, worth $25K.
Companies traded
Other insiders at ANTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$53K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Eizen Joshua M made?
Eizen Joshua M has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Eizen Joshua M trade?
Eizen Joshua M has filed SEC Form 4 disclosures for 1 company, including ANTX.
When was Eizen Joshua M's most recent SEC Form 4 filing?
Eizen Joshua M's most recent SEC Form 4 filing on Tracefour is dated Jul 10, 2026.
What is Eizen Joshua M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Eizen Joshua M is listed as See Remarks.
What is Eizen Joshua M's total buy and sell value in the current window?
Inside the rolling retention window, Eizen Joshua M bought $0 and sold $53K based on SEC Form 4 filings.
What was Eizen Joshua M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,945 ANTX shares on 2026-07-08, worth $25K, per SEC Form 4 filings.